Planning to commercialize your biomarker discovery? The Biomarker Commercialization – BIC BRIDGE project offers tools, which support and guide the commercialization process of new in vitro diagnostics (IVD) applicable biomarkers. The tools include a Biomarker Commercialization Guide, a Best Practices Handbook, an IVD Regulatory Guide, and a Review Tool. BIC BRIDGE is co-financed by the European Regional Development Fund through the Interreg Baltic Sea Region Programme.
More than 65,000 researchers across 90 countries are using Castor EDC, eConsent, ePRO, API, and eSource to supercharge their research. Castor’s platform has supported more than 4,100 commercial and academic studies that cover a broad range of disease areas including cardiovascular disease, central nervous system, rare diseases, infectious diseases, and oncology.
Castor’s team can also conduct study design, build, and data management.
Dutch contract manufacturing company and product development partner, specialized in engineering, manufacturing, assembly and quality control of medical devices or subassemblies in China, ISO 9001:2015 and ISO13485 certified. We have realized physiotherapist equipment for Enraf-Nonius B.V., Wheelchair legrests and subassemblies for Sunrise Medical, the Armon Armsupport and the UV desinfection device for UVsmart. We are also looking to invest in scale-up companies.
Clubster NHL – Nutrition, Health, Longevity – is a French competitiveness cluster federating 350 members in the Nutrition, biotechnology and health sectors. We foster collaboration between academia, private companies (start-up, SMEs and large companies), clinicians and final users. Our aim is to help our members to design, develop and finance their innovative products and processes. The activity encompasses the ONE HEALTH concept, close relation between human, animal and plant health.
CoBra project aims to improve quality of both diagnosis and treatment of localized cancers, by developing a new medical robot prototype for brachytherapy and biopsy under guidance of MRI. The overall objective of the project is to enhance the patient’s quality of life and reduce their cancer mortality. The prostate and other soft tissues will be the main localized cancers of interest in the Cobra project.
Demcon develops and realises medical systems for diagnosis, therapy, care and self-care. Applications are found in fields including surgery, therapy and diagnostics. Examples include an operating system for eye surgery, a hand scanner for rheumatoid arthritis, a ventilator or a hearing aid. Clients may be medical technology start-ups or established small and medium-sized enterprises or major OEMs.
We are a 3D imaging company based in Spain. We have developed a new plenoptic technology to provide SMART products for clinical, biological, and industrial applications Doitplenoptic is a spin-off company from the University of Valencia.
ECsens was established in 2020 as a spin-off from the University of Twente (The Netherlands). A disruptive nanotechnology-based biosensing method was developed, allowing to detect individual submicroscopic biomarkers. ECsens is currently validating this technology for applications in cancer patient monitoring, real-time COPD exacerbation diagnosis and developing rapid, cheap and reliable COVID test.
EDUCAT (Empowerment of Disabled people through the User Coproduction of Assistive Technology) is an European funded project to develop and deliver adaptive, open and modular technology to promote independence and improve quality of life for people with motor impairment and neurological disorders.
ENSWEET® develops a telemedicine solution allowing patients with long-term illness to carry out their rehabilitation stay outside health establishments. With ENSWEET®, you can create hybrid paths between your establishments and the patient’s home.
Our mission: to make rehabilitation care accessible to all.
éolane: a global solution from the conception to the manufacturing of your medical devices.
Our mission: From class 1 to class 3 Medical device, éolane brings you global solution from the concept to the mass production.
Set up on 1st January 2000, EFS is the only public blood transfusion organization in France. The core mission of EFS is to ensure national self-sufficiency in blood products under optimal conditions of safety and quality. EFS manages the collection, screening, processing and distribution of labile blood products to health-care establishments.
Beyond its blood transfusion activity, EFS has developed a wide range of activities intended to promote progress for the benefit of patient.
Eurasanté is a development agency dedicated to tech transfer and business development in life sciences sector in Northern France region. Our experienced project managers help researchers, startups and companies with their development projects. To do so, Eurasante provides many services such as real estate, fundraising, recruitment and business development. It also promotes the Eurasante Bio-business Park, which already hosts 8 hospitals, 4 universities, 8 specialised schools and more than 170 companies. It benefits from an exceptional location at the heart of Europe.
EUROBIOMED is the catalyst of the health sector in Southern France. EUROBIOMED leads territorial initiatives, provides resources and offers solutions for businesses and research organizations. EUROBIOMED helps them to innovate, finance, develop and achieve their strategic and business objectives to ultimately improve life through innovations in health. EUROBIOMED tops European rankings in all stages of innovation. Together, the + 400 EUROBIOMED members are a driving force in regional development (with 298 projects, representing +1 billion Euros).
“Carnot institute” is label awarded to research centers of excellence which have been able to demonstrate their ability to conduct research projects with industry at highest quality standards. Members of the consortium include Institut Pasteur, Institut Curie, Institut du Cerveau, Institut de la Vision, Institut Imagine (genetic diseases), Institut Calym (lymphoma), INRAE, CEA, …
Innovation network Health Valley unites companies, care organisations, knowledge institutes and authorities, and enables them to grow stronger together. Whether we’re providing developers with care needs and requirements or delivering innovations to the patient: we bring technology to the care sector, together. Through a combination of innovative, market and entrepreneurial strength, our partners give an unmistakable boost to the care sector and also encourage economic growth.
The world is changing rapidly and that means that the lifecycle of products is becoming ever shorter. In order to keep ahead of this, it is important to think deeply about the products even in the design phase. They need to be as reliable as possible, have the potential to be brought to the market quickly, and, above all, they need to meet the expectations and requirements of the customer.
i2S MedCare has been helping his customers to take up their most complex challenges using imaging in the areas of health and wellness with expertise in the development of specialized cameras integrated in medical O.E.M devices and connected portable tools. Our support offer goes from the implementation of your projects to the management of clinical data thanks to our e-health imaging software solutions associated with devices.
At IamFluidics we are passionate about engineering high-quality microparticles to create disruptive solutions that improve life quality. We strongly focus on technological innovations in microfluidics and materials for personal care, life science, pharmaceutical, and biomedical products. We care about learning continuously, innovating through science, contributing to life quality, creating a great place to work, and providing impactful, scalable, and sustainable solutions.
ICOSA is an intellectual property firm dedicated to the health sector and specialized in Life Sciences and Medtech.
We operate at all the stages of the protection of the Intellectual Property, by filing patents and trademarks, by elaborating strategies of Industrial Property, by issuing Legal Opinions on the patentability or the freedom to operate and by financially evaluating the value of portfolios of Intellectual Property assets.
IMODE is a collaborative research project for multicomponent pharmaceutical products (co-amorphous and co-crystals) and medical devices that are loaded with bioactive molecules. Started in 2016, the IMODE project is funded by the European Interreg 2 Seas programme and co-financed by the European Regional Development Fund (ERDF).
Specialist in functional materials, surfaces and interfaces, Carnot MICA Institute supports companies in the design and development of their products and services. With its 18 laboratories and technical centers, all experts in materials and innovative solutions, Carnot MICA Institute offers companies a complete range of services, ranging from fundamental research to industrial applications. Boost your R&D with Carnot MICA Institute !
lifespin – metabolite profiling and precision diagnostics
• technology and software for metabolite profiling
• database with thousands of individual digital metabolic images
• extensive IVD pipeline
• NMR-services and software solutions for R&D and clinical routine
The portfolio ranges from standardized biomarker profiles in human biofluids, customized accompaniement of your R&D and clinical studies to joint biomarker research and IVD development.
M.O.T.I.O.N aims to co-build, validate a bionic rehabilitation technologies, an exoskeleton and a smart garment for children with cerebral palsy trough a cross-regional dissemination network. The Leader of the consortium is Junia and coordinates the differents actions of the members of the consortium. End users are involved through the different clinical trials and survey.Eight observers, an international advisory board, and 4 national ones guide the consortium in its strategy
Machnet Medical Robotics (MMR), has developed MRI compatible robotic technology, currently under evaluation for biopsy needle positioning with an unprecedented precision. The robotic solution is based upon research performed in collaboration with the University of Twente and is aiming towards increasing the accuracy of a biopsy procedure as well as improving the workflow (i.e. time it takes to complete the procedure) significantly.
Founded in 2000, MEDICALPS is a NPO and a cluster of companies in the field of healthcare technologies. It is located in Grenoble, in the heart of the French Alps, known as one of the most inventive cities in the world and a top-notch place to innovate in the high-tech industry. MEDICALPS gathers over 100 members including leading edge startups, SMEs, global players, world-class research centres and universities.
Our services cover all steps of product development, from the initial project idea to certification or regulatory clearance. As professionals with a multidisciplinary background, we provide the necessary competencies internally to handle all aspects of your project, from the Design to the Certification. Our team expends regularly to provide the best resources and competencies to address all dimensions of your project and to reach the ambitious milestones required by the marketing of your product.
Ready to consult, design, conduct and submit preclinical studies you need for your product. We are flexible, effective and affordable.
– advanced tox studies supporting phase I – III CT
– expertise in non-rodent (HNP, dogs, pigs, cats, rabbits, ferrets) and rodent tox
– human & veterinary products (small molecules, vaccines, biotech derived, medical device
– revision of study documentation, implementation GLP
– GLP certified 1991
– CIR certified
Medspray Anesthesia B.V. supplies the innovative spray nozzle device to end users in hospitals and clinics. The Trachospray device is equipped with spray nozzle technology from the affiliate company Medspray. The Trachospray provides topical anesthesia to the upper airway in a convenient mode for both patient and clinician. The Trachospray device offers a non-intimidating procedure to the patient and enhances patient comfort in preparation for a bronchoscopy or upper GI endoscopy.
Since our beginning, 60 years ago, our Mission has remained the same: to alleviate pain, restore health, and extend life for people around the world. The Mission is our ethical framework and inspirational goal guiding our day-to-day work. It reminds us that our efforts are transforming millions of lives each year.
MyData-Trust is a Belgian company specialized in Data Protection and exclusively dedicated to clinical research.
The aim of MyData-TRUST consists in providing strategic, operational and organizational support, making important contribution both legally and technically to the success of the Data Protection implementation and the company as a whole. We provide services solutions aligned with both clinical research and Data Protection requirements: Data Security, GDPR, HIPAA, CCPA, PIPEDA ect
Open Stent Solution (OSS) develops the first longitudinally expandable valved stent, paving the way for the new open stent concept for the treatment of heart valve disease.
With its pioneering technology, Open Stent Solution aims to provide a non-invasive solution for transcatheter mitral and tricuspid valve replacement for patients at high surgical risk. Open Stent Solution develops best-in-class technologies that address multiple unmet needs in the field of heart valve disease.
We have more than 13 years of experience in biosignals field. Our products are focused on facilitating education and research in biomedical field and providing access to healthcare through remote monitoring and treatment solutions.
Surgical management of genital prolapse is becoming more and more frequent, but current solutions are inadequate. Indeed, the existing systems currently in place are poorly adapted and too rigid.The Probiomesh project aims to improve surgical management of genital prolapse through the creation of new textile implants. These new implants will be semi-resorbable and will have mechanical properties perfectly adapted to this problem.
PureLab Plastics, specialized in development and injection molding in controled environment, offers expertise fully dedicated to Life Sciences, medical and pharmaceutical technologies. We offer a full-service including :
– an engineering team of experts from project design all the way through industrialization
– Scientific Injection Molding and Eco-Design approach
– Compliant manufacturing environment (ISO7–ISO8–ISO9) and Quality (ISO13485-ISO14001-cGMP’s)
– Flexible manufacturing and services
The Technical Medical Centre is a leading Innovation Hub impacting healthcare by excellent Research, Innovation and Education. The TechMed Centre boosts innovation by; connecting stakeholders, access to state-of-the-art facilities, funds and voucher programs and by offering our extensive experience in Tech Transfer. The TechMed Centre displays excellence in the domains of; Imaging and diagnostics, Bioengineering technologies, Biorobotics, Medical physiology and Health, well-being & technology.
The aim of the TEXTOS project is to create a hybrid “matrix” combining the two functions: structure and bioactivity to meet the mechanical requirements of biological tissue, as well as the biological requirements necessary for proper tissue regeneration.
As a member of the global WTCA community, WTC Twente is supporting enterprises in the EastNetherlands in their international ambitions, while helping them to establish trustworthy partnerships and healthy businesses abroad. Trade missions are an excellent way, for the companies considering international expansion, to get a feeling of the market, to establish contacts with potential trade and know-how partners. We also support foreign companies to find business partners in The Netherlands.
MedFIT is your unique opportunity to connect with international key innovators in the MedTech, diagnostic and digital health sectors. As a leading European partnering event, MedFIT provides the ideal environment to build partnerships for all public and private actors, to source innovative and competitive early-stage R&D projects, to speed the emergence of collaborative projects, to increase licensing opportunities, to obtain funding and to facilitate market access. Learn more
WARNING: Some fraudulent companies are supposedly providing the attendees list of MedFIT. And some are passing themselves off as being MedFIT organisation members and asking you to pay. Please note that the MedFIT team will never sell you the MedFIT attendees list and never ask for your bank account details to make you pay for hotel bookings, exhibition fees or others, and certainly not over the phone.Please be extremely vigilant.
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behaviour or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.